Erasca (ERAS) Treasury Shares (2020 - 2022)

Erasca (ERAS) posted Treasury Shares of $38810.0 for Q2 2022, down 67.6% on a QoQ basis from $119798.0 in Q1 2022, and down 99.95% year-over-year from $85.5 million in Q2 2021.

Erasca (ERAS) Treasury Shares (2020 - 2022) Analysis & Trends

Erasca's Treasury Shares history runs 3 years deep, the most recent figure standing at $38810.0 for Q2 2022.

  • Quarterly Treasury Shares fell 99.95% year-over-year to $38810.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $38810.0 (down 99.95% YoY) and the FY2021 annual result came in at $212941.0, down 99.69% from the prior year.
  • Treasury Shares was $38810.0 for Q2 2022 at Erasca, down from $119798.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $85.5 million in Q1 2021 and bottomed at $38810.0 in Q2 2022.
  • A 3-year average of $41.1 million and a median of $63.2 million in 2020 frame the typical range for Treasury Shares.
  • Annual changes were most pronounced in 2021 — Treasury Shares surged 35.34% — and 2022, when it tumbled 99.95%.
  • Erasca's Treasury Shares stood at $69.6 million in 2020, then slumped by 99.69% to $212941.0 in 2021, then plunged by 81.77% to $38810.0 in 2022.
  • Business Quant data shows ERAS's Treasury Shares at $38810.0 in Q2 2022, $119798.0 in Q1 2022, and $212941.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -21,709.08
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - 265,401.92
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn -
10 Erasca 5.83 Bn 5.59 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 38,810.00
Jun 30, 2022 38,810.00
Mar 31, 2022 119,798.00
Mar 31, 2022 119,798.00
Dec 31, 2021 212,941.00
Dec 31, 2021 212,941.00
Sep 30, 2021 299,139.00
Sep 30, 2021 299,139.00
Jun 30, 2021 85.52 Mn
Jun 30, 2021 85.52 Mn
Mar 31, 2021 85.52 Mn
Mar 31, 2021 85.52 Mn
Dec 31, 2020 69.58 Mn
Dec 31, 2020 69.58 Mn
Sep 30, 2020 65.58 Mn
Sep 30, 2020 65.58 Mn
Jun 30, 2020 63.18 Mn
Jun 30, 2020 63.18 Mn